10-QThe Record
Keros Therapeutics, Inc. files 10-Q
Filed Aug 4, 2022 · 3y ago · Accession 0001664710-22-000040
Plain English
Quarterly report — three-month financials and management discussion.
Read the source below for the full document.
Filing details
- Company
- Keros Therapeutics, Inc.
- Ticker
- KROS
- CIK
- 1664710
- Form type
- 10-Q
- Filing date
- Aug 4, 2022
- Report date
- Jun 30, 2022
- Document
- kros-20220630.htm
- Size
- 3.9 MB